Tafluprost Ophthalmic Side Effects

Medically reviewed by Drugs.com. Last updated on Oct 15, 2024.

Applies to tafluprost ophthalmic: ophthalmic solution.

Precautions

Your eye doctor will want to examine your eyes at regular visits to make sure that the medicine is working properly and is not causing unwanted effects.

This medicine may cause a brown color in the iris (colored part), eyelid, or eyelashes of your treated eye. Your eyelashes may also become longer, thicker, and darker. Some of these changes may be permanent even if you stop using tafluprost. Check with your doctor if you have any questions about this.

Check with your doctor right away if you have an eye injury, eye infection, or plan to have eye surgery.

Other side effects

Some side effects of tafluprost ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Serious side effects

Along with its needed effects, tafluprost ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking tafluprost ophthalmic:

For healthcare professionals

Applies to tafluprost ophthalmic: ophthalmic solution.

General adverse events

The most commonly reported side effect was conjunctival/ocular hyperemia.^[Ref]

Nervous system

• Common (1% to 10%): Headache^[Ref]

Ocular

• Common (1% to 10%): Ocular stinging/irritation, ocular pruritus including allergic conjunctivitis, cataract, dry eye, ocular pain, eyelash darkening, growth of eyelashes, blurred vision, increased lacrimation, eyelid erythema, foreign body sensation in the eyes, photophobia, reduced visual acuity, punctate keratitis, eye discharge, eyelid edema, iris hyperpigmentation, conjunctival/ocular hyperemia
• Uncommon (0.1 to 1%): Blepharal pigmentation, asthenopia, conjunctival edema, blepharitis, anterior chamber cells, ocular discomfort, anterior chamber flare, conjunctival pigmentation, conjunctival follicles, allergic conjunctivitis
• Very rare (less than 0.01%): Corneal calcification (in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas)
• Frequency not reported: Deepening of the eyelid sulcus, iritis/uveitis^[Ref]

Genitourinary

• Common (1% to 10%): Urinary tract infection^[Ref]

Respiratory

• Common (1% to 10%): Cough
• Postmarketing reports: Exacerbation of asthma, dyspnea^[Ref]

Dermatologic

• Uncommon (0.1% to 1%): Hypertrichosis of the eyelid^[Ref]

Immunologic

• Common (1% to 10%): Common cold^[Ref]

See also:

Further information

Tafluprost ophthalmic side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer